(±)-Atenolol

Confirm delete?

(±)-Atenolol

Zoom

Cat No: 17250

Biochemicals - Receptor Pharmacology

(±)-Atenolol is an antagonist of the β1-adrenergic receptor (β1-AR; Ki = 1.14 µM).{28226} It is selective for β1-ARs over β2-ARs (Ki = 48.7 µM). (±)-Atenolol (200 mg/kg per day) delays the onset of hypertension in spontaneously hypertensive rats.{4950...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-benzeneacetamide

Correlated keywords:

?-adrenoceptor antagonist ?-blocker cardiovascular disease hypertension 60966-51-0 106020-65-9 ± Aten Alinor Altol Anselol Apo-Atenolol ApoAtenolol Atecard Atcardil Atelol Atendol Antipressan AteHexal Aterol DL Catenol Catenolol Coratol Corotenol Cuxanorm Evitocor Farnormin Felo-Bits Ibinolo Internolol Juvental Lo-ten Lotenal Myocord Normalol Normiten Noten Novaten Oraday Premorine Prenolol Prenormine Seles Beta Selobloc Serten Stermin Telol Tenidon Teno-basan Tenoblock Tenolin Tenolol Tenoprin Tenordin Tenormine Tensig Tensimin Tredol Uniloc Urosin Vascoten Vericordin Wesipin Xaten Blockium Hipres Hypoten ICI66082 ?1-adrenergic receptor ?2 enantiomer block racemic cardiology vascular biochemical J61199 Tenormin

Product Overview:
(±)-Atenolol is an antagonist of the β1-adrenergic receptor (β1-AR; Ki = 1.14 µM).{28226} It is selective for β1-ARs over β2-ARs (Ki = 48.7 µM). (±)-Atenolol (200 mg/kg per day) delays the onset of hypertension in spontaneously hypertensive rats.{49503} Formulations containing atenolol have been used in the treatment of high blood pressure.

Size	1 g
Shipping	dry ice
CAS Number	29122-68-7
Molecular Formula	C₁₄H₂₂N₂O₃
SMILES	NC(CC1=CC=C(OCC(O)CNC(C)C)C=C1)=O
Molecular Weight	266,3
Formulation	A crystalline solid
Purity	≥98%
Custom Code	2916.39
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.